SEC Commissioner Peirce calls crypto self-custody a fundamental right

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights
  • Hester Peirce criticized rules restricting crypto investments compared to gambling
  • Proposed $5 million simplified exemption and $75 million stricter option for capital raising
  • Advocated for tokenized stocks trading via automated market makers on blockchains
  • Described crypto self-custody as a fundamental American right requiring regulatory preservation
powered bylight_fuzz_icon
52173857

*this image is generated using AI for illustrative purposes only.

SEC Commissioner Hester Peirce has criticized current regulations that restrict ordinary Americans from investing in businesses and crypto projects while permitting unrestricted gambling. Speaking on Sunday, Peirce argued that regulators should protect investors without "infantilizing" them, advocating for greater freedom in capital allocation.

Peirce, who is preparing to leave the SEC, outlined specific frameworks to ease crypto investing during an interview with Scott Melker. She proposed two distinct approaches for raising capital:

  • Allow crypto projects to raise up to $5 million under a simplified startup exemption.
  • Permit projects to raise up to $75 million with stricter regulatory requirements.

This framework could also allow a token to eventually separate from the investment contract used for its initial sale once the project’s promised work is completed. Peirce noted that previous rules created wrong incentives, where projects claiming their tokens had no utility faced fewer regulatory hurdles than those building useful products.

Tokenized stocks and innovation exemptions

Peirce suggested that the SEC innovation exemption could enable tokenized stocks to trade through automated market makers on permissionless blockchains. These tokenized securities would retain the same rights as underlying shares, including voting and dividends, while issuers would retain the right to object to tokenization. She emphasized that the U.S. should encourage such experimentation rather than pushing it overseas. Despite the failure of the CLARITY Act, Peirce stated that the SEC can still address several crypto issues under its existing authority.

Self-custody as a fundamental right

Peirce described crypto self-custody as a "very fundamental American right," asserting that individuals should be free to hold assets themselves or use intermediaries. She concluded that regulators should preserve the right to self-custody and use decentralized tools, while applying different rules to financial intermediaries.

Proposal Capital Limit Regulatory Requirement
Simplified Startup Exemption $5 million Simplified process
Higher Cap Option $75 million Stricter requirements

The divergence between the $5 million and $75 million thresholds highlights a tiered approach to investor protection, balancing accessibility for early-stage projects with safeguards for larger offerings.

Historical Stock Returns for Hester Biosciences

1 Day5 Days1 Month6 Months1 Year5 Years
+0.82%-0.63%-5.96%+64.34%+12.80%-12.75%
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might Peirce's departure impact the likelihood of the SEC adopting her proposed tiered capital exemption frameworks before new leadership is confirmed?

What specific regulatory mechanisms would be required to enforce issuer objections to tokenized stock trading while maintaining the permissionless nature of automated market makers?

Could the proposed $75 million threshold inadvertently create a regulatory arbitrage opportunity for projects seeking to bypass traditional IPO requirements?

Hester Biosciences closes trading window from October 1 for Q2FY27

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Trading window closed from October 1, 2026
  • Closure applies to Q2FY27 and H1FY27 results
  • Window reopens 48 hours after results are public
  • Compliance with SEBI insider trading regulations
powered bylight_fuzz_icon
51855658

*this image is generated using AI for illustrative purposes only.

Hester Biosciences has closed its trading window for dealing in equity shares starting October 1, 2026. This measure is implemented ahead of the announcement of financial results for the quarter and six months ended September 30, 2026.

Regulatory compliance and timeline

The company stated that the closure is pursuant to the SEBI (Prohibition of Insider Trading) Regulations and its internal code of conduct. This code regulates and monitors trading by directors, promoters, designated employees, specified connected persons, and material subsidiaries, including their immediate relatives.

The trading window will remain closed until 48 hours after the financial results become generally available as public information. This standard protocol ensures that insiders do not trade while possessing unpublished price-sensitive information.

Key dates and details

Detail Information
Company Hester Biosciences
Closure Start Date October 1, 2026
Reporting Period Q2FY27 and H1FY27
Period End Date September 30, 2026
Reopening Condition 48 hours post-publication

The communication was signed by Vinod Mali, Company Secretary and Compliance Officer, on September 25, 2026. The notice was filed with both BSE Limited and the National Stock Exchange of India Limited.

Historical Stock Returns for Hester Biosciences

1 Day5 Days1 Month6 Months1 Year5 Years
+0.82%-0.63%-5.96%+64.34%+12.80%-12.75%

How might Hester Biosciences' Q2FY27 revenue performance compare to the previous quarter given recent trends in the veterinary vaccine market?

What impact could the upcoming financial results have on Hester Biosciences' stock volatility once the trading window reopens?

Are there any pending regulatory approvals or new product launches expected to influence the company's earnings outlook for FY27?

More News on Hester Biosciences

1 Year Returns:+12.80%